...
首页> 外文期刊>Journal of the American Medical Directors Association >Deprescribing as a Clinical Improvement Focus
【24h】

Deprescribing as a Clinical Improvement Focus

机译:作为临床改善重点的剥夺

获取原文
获取原文并翻译 | 示例

摘要

Objectives: Polypharmacy is a concern in the practice of geriatrics because of consequences such as adverse drug events and poorer quality of life. Deprescribing, a response to polypharmacy, refers to the systematic, programmed, and appropriate reduction in drug number and dose. Although now broadly recognized, challenges exist in practice for effective implementation. This study was conducted to determine the deprescribing success rate and relate it to drug classes and clinical settings, and to identify factors that influence the deprescribing process.
机译:目的:多药病是对老年教学的实践的关注,因为诸如不良药物事件和较差的生活质量等后果。 贬低,对多酚省期的反应是指系统,编程和药物数量和剂量的适当降低。 虽然现在广泛认识到,有效实施的实践中存在挑战。 进行了本研究以确定贬略的成功率并将其与药物课程和临床环境相关联,并确定影响剥夺过程的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号